PURE Bioscience, Inc. announced earnings results for the third quarter ended April 30, 2021. For the third quarter, the company announced total revenue was USD 561,000 compared to USD 2.221 million a year ago. Operating loss was USD 810,000 compared to operating Income of USD 474,000 a year ago. Net loss was USD 811,000 compared to net income of USD 473,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to basic earnings per share from continuing operations of USD 0.01 a year ago. For the nine months, total revenue was USD 3.068 million compared to USD 2.968 million a year ago. Operating loss was USD 1.583 million compared to USD 1.319 million a year ago. Net loss was USD 1.586 million compared to USD 1.318 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.